John P. Butler
CEO and President at Akebia Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Akebia Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Akebia Therapeutics Inc. June 10, 202586.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 6, 2026 | Akebia Therapeutics Inc. | Option exercise | +350,000 | $0.63 | $220,500 |
| Mar 4, 2026 | Akebia Therapeutics Inc. | Open-market purchase | +69,270 | $1.25 | $86,588 |
| Feb 2, 2026 | Akebia Therapeutics Inc. | Open-market sale | −46,660 | $1.39 | $64,857 |
| Feb 2, 2026 | Akebia Therapeutics Inc. | Open-market sale | −96,065 | $1.39 | $133,530 |
| Feb 2, 2026 | Akebia Therapeutics Inc. | Open-market sale | −114,891 | $1.39 | $159,698 |
| Feb 2, 2026 | Akebia Therapeutics Inc. | Grant or award | +175,250 | $1.41 | $247,103 |
| Feb 2, 2026 | Akebia Therapeutics Inc. | Open-market sale | −83,689 | $1.39 | $116,328 |
| Jan 30, 2026 | Akebia Therapeutics Inc. | Grant or award | +743,000 | — | — |
| Mar 3, 2025 | Akebia Therapeutics Inc. | Open-market sale | −46,409 | $1.83 | $84,928 |
| Feb 3, 2025 | Akebia Therapeutics Inc. | Open-market sale | −46,268 | $2.10 | $97,163 |
| Feb 3, 2025 | Akebia Therapeutics Inc. | Open-market sale | −97,982 | $2.10 | $205,762 |
| Jan 31, 2025 | Akebia Therapeutics Inc. | Grant or award | +701,000 | — | — |
| Feb 29, 2024 | Akebia Therapeutics Inc. | Open-market sale | −46,570 | $1.58 | $73,581 |
| Feb 27, 2024 | Akebia Therapeutics Inc. | Open-market sale | −37,733 | $1.52 | $57,354 |
| Feb 1, 2024 | Akebia Therapeutics Inc. | Open-market sale | −46,489 | $1.68 | $78,102 |
Questions about John P. Butler
What boards is John P. Butler on?
John P. Butler sits on the board of Akebia Therapeutics Inc.
What company is John P. Butler the CEO of?
John P. Butler is CEO and President of Akebia Therapeutics Inc.
How long has John P. Butler served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.